{
    "success": true,
    "data": {
        "id": 1104620,
        "msgid": "high-dosage-drugs-still-widely-available-sampurno-1447893297",
        "date": "2001-05-09 00:00:00",
        "title": "High dosage drugs still widely available: Sampurno",
        "author": null,
        "source": "JP",
        "tags": null,
        "topic": null,
        "summary": "High dosage drugs still widely available: Sampurno JAKARTA (JP): Flu and cough medicines containing more than 15 milligrams of phenylpropanolamine (PPA) are still widely available despite the government's May 8 deadline for withdrawal of the products.",
        "content": "<p>High dosage drugs still widely available: Sampurno<\/p>\n<p>JAKARTA (JP): Flu and cough medicines containing more than 15<br>\nmilligrams of phenylpropanolamine (PPA) are still widely<br>\navailable despite the government's May 8 deadline for withdrawal<br>\nof the products.<\/p>\n<p>Food and Drug Control Agency (BPOM) head Sampurno said that<br>\nthe government had given pharmaceutical companies since December<br>\nto withdraw their old products from the market and replace them<br>\nwith products containing a reduced PPA content, which should not<br>\nexceed 15 milligrams per dosage.<\/p>\n<p>According to Sampurno, most drug producers have obeyed the<br>\ngovernment regulation. He praised the companies for their quick<br>\nresponse in adhering to government policy.<\/p>\n<p>He said that, out of the 65 products which had been withdrawn<br>\nfrom the market, 48 of them had been reformulated, while 17 are<br>\nno longer produced.<\/p>\n<p>Sampurno admitted that it was difficult to control sales at<br>\nunlicensed drug stores, such as kiosks.<\/p>\n<p>\"We're aware that some medicines containing more than the<br>\napproved PPA content are still available in many small shops.<br>\nHowever, efforts to withdraw them from the market are still<br>\ncontinuing,\" Sampurno told The Jakarta Post by telephone on<br>\nTuesday.<\/p>\n<p>In December, the agency warned drug producers to strictly<br>\nabide by the new rule and threatened severe sanctions to those<br>\nwhich did not.<\/p>\n<p>The companies are not only obliged to reformulate with a<br>\nreduced PPA content, but to also print a warning on the<br>\nmedicines' packaging and brochures, alerting customers to the<br>\ndangers of the substance.<\/p>\n<p>The government had warned that lengthy use or an overdose of<br>\nPPA could cause hemorrhagic stroke and high blood pressure.<\/p>\n<p>There are 189 brands of flu and cough medicines containing PPA<br>\nproduced by 79 pharmaceutical firms in the country.<\/p>\n<p>According to data released in December by the Foundation to<br>\nEmpower Indonesian Health Consumers (YPKKI), no less than 76<br>\nover-the-counter brands had a PPA content higher than 15<br>\nmilligrams.<\/p>\n<p>They include the popular Neozep, Mixagrip, Procold, Stop Cold,<br>\nBodrex, Contrex, Ultraflu and Flugan.<\/p>\n<p>The use of PPA is considered safe if it does not exceed 75<br>\nmilligrams per day for adults and 37.5 milligrams per day for<br>\nchildren between six and 12 years of age, Sampurno said.<\/p>\n<p>PPA is an active substance commonly used as a decongestant<br>\nand, until recently, many popular medicines sold over the counter<br>\ncontained 25 milligrams of PPA.<\/p>\n<p>In countries such as the United States, PPA is also widely<br>\nused in diet pills to help suppress appetite.<\/p>\n<p>Sampurno said that the effects of PPA in the decongestants are<br>\nnot really lethal but, as the government had made an<br>\ninternational commitment, the agency was required to supervise<br>\nusage of the substance.<\/p>\n<p>Separately, Uung Sendana, sales manager of pharmaceutical<br>\ncompany PT Dankos Laboratories, the producer of Mixagrip, said<br>\nthat since January the company and its distributors had been<br>\nrecalling their products and replacing them with new products<br>\ncontaining a lower PPA content.<\/p>\n<p>\"However, how can we recall our products from small kiosks<br>\nwhich are not aware of the government warning?\" Uung told the<br>\nPost on Tuesday.<\/p>\n<p>A PT Medifarma Laboratories Inc. employee said that their<br>\nproduct Decolgen only contains 12.5 milligrams of PPA, but was<br>\nrecalled because there was no warning box on the package.<\/p>\n<p>YPKKI chairman Marius Widjajarta has a different view.<\/p>\n<p>Marius alleged that many companies are only repackaging their<br>\nproduct, while continuing to sell the previous medication with a<br>\nhigh PPA content.<\/p>\n<p>He said it was difficult to check the actual PPA content of<br>\neach drug.<\/p>\n<p>According to him, only Sampurno's office and the producers<br>\nhave suitable equipment for checking the content.<\/p>\n<p>\"I suspect the possibility of repackaging from flu and cough<br>\nmedicine producers where PPA content is more than 15 percent,\"<br>\nMarius said. (bby)<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/high-dosage-drugs-still-widely-available-sampurno-1447893297",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}